Literature DB >> 27153487

Rescuing the Lost in Translation.

Sinje Gehr1, Craig C Garner2.   

Abstract

The translation of medically relevant academic inventions that could transform public health has been notoriously difficult, stemming largely from cultural differences been academia and industry. New initiatives to kindle academic entrepreneurship and establish stronger public/private partnerships are helping to align these differences and accelerating the translation of promising new therapies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27153487     DOI: 10.1016/j.cell.2016.04.043

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  7 in total

Review 1.  Joint academic and industrial efforts towards innovative and efficient solutions for clinical needs.

Authors:  Andrea De Pieri; Sofia Ribeiro; Dimitrios Tsiapalis; David Eglin; Marc Bohner; Peter Dubruel; Philip Procter; Dimitrios I Zeugolis; Yves Bayon
Journal:  J Mater Sci Mater Med       Date:  2018-07-31       Impact factor: 3.896

2.  Translational Research Symposium-collaborative efforts as driving forces of healthcare innovation.

Authors:  João Q Coentro; Andrea De Pieri; Diana Gaspar; Dimitrios Tsiapalis; Dimitrios I Zeugolis; Yves Bayon
Journal:  J Mater Sci Mater Med       Date:  2019-12-02       Impact factor: 3.896

3.  Fostering innovation at Academic Medical Centers: The Case of University of Colorado Anschutz Medical Campus.

Authors:  Cigdem H Benam; Gali Baler; Richard Duke; Demetria M McNeal; Kimberly A Muller; Cathy Bodine; Elaine H Morrato; Ronald J Sokol
Journal:  J Clin Transl Sci       Date:  2021-05-17

Review 4.  Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.

Authors:  Remco L A de Vrueh; Daan J A Crommelin
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200

Review 5.  On the road to smart biomaterials for bone research: definitions, concepts, advances, and outlook.

Authors:  Carolina Montoya; Yu Du; Anthony L Gianforcaro; Santiago Orrego; Maobin Yang; Peter I Lelkes
Journal:  Bone Res       Date:  2021-02-11       Impact factor: 13.567

6.  External validity in translational biomedicine: understanding the conditions enabling the cause to have an effect.

Authors:  Ulrich Dirnagl; Alexandra Bannach-Brown; Sarah McCann
Journal:  EMBO Mol Med       Date:  2021-12-20       Impact factor: 12.137

Review 7.  Improving target assessment in biomedical research: the GOT-IT recommendations.

Authors:  Christoph H Emmerich; Lorena Martinez Gamboa; Martine C J Hofmann; Marc Bonin-Andresen; Olga Arbach; Pascal Schendel; Björn Gerlach; Katja Hempel; Anton Bespalov; Ulrich Dirnagl; Michael J Parnham
Journal:  Nat Rev Drug Discov       Date:  2020-11-16       Impact factor: 112.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.